Authors: Birkenkamp, KU Esselink, MT Kruijer, W Vellenga, E

Citation: Ku. Birkenkamp et al., An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation, EXP HEMATOL, 28(11), 2000, pp. 1239-1249

Authors: Birkenkamp, KU Tuyt, LML Lummen, C Wierenga, LTJ Kruijer, W Vellenga, E

Citation: Ku. Birkenkamp et al., The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway, BR J PHARM, 131(1), 2000, pp. 99-107

Authors: Birkenkamp, KU Esselink, MT Kruijer, W Vellenga, E

Citation: Ku. Birkenkamp et al., Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; theinvolvement of ERK, p38 and STAT5, EUR CYTOKIN, 10(4), 1999, pp. 479-490

Authors: Lugones, LG Wosten, HAB Birkenkamp, KU Sjollema, KA Zagers, J Wessels, JGH

Citation: Lg. Lugones et al., Hydrophobins line air channels in fruiting bodies of Schizophyllum communeand Agaricus bisporus, MYCOL RES, 103, 1999, pp. 635-640

Authors: Birkenkamp, KU Dokter, WHA Esselink, MT Jonk, LJC Kruijer, W Vellenga, E

Citation: Ku. Birkenkamp et al., A dual function for p38 MAP kinase in hematopoietic cells: involvement in apoptosis and cell activation, LEUKEMIA, 13(7), 1999, pp. 1037-1045